Recommending form of anticancer drugs in oncology unit of a tertiary care teaching hospital

Pandiamunian Jayabal (1) , Nithiya Dhanasekaran (2) , Shanmugasundaram S (3)
(1) Department of Pharmacology, Vinayaka Mission’s Medical College and Hospital, Vinayaka Mission Research Foundation (Deemed to be University), Karaikal, Puducherry, India, India ,
(2) Vijayanagara Institute of Medical Sciences, Ballary-583104, Karnataka, India, India ,
(3) Department of Surgery, Vinayaka Mission’s Medical College and Hospital, Vinayaka Mission Research Foundation (Deemed to be University), Karaikal, Puducherry, India, India

Abstract

Cancer has become a chief ailment and danger to the global society. It is one of the foremost reasons for demise in the world. A survey by the World Health Organization (WHO) indicates that 8.2 million people died from cancer in 2012 and it may rise to 19 million by 2025. Drug interactions connected through anticancer drugs are a global concern and should not be ignored. Nausea, vomiting or some other mild response to extreme myelosuppression may vary from adverse drug reactions. Analysis of prescription trend is a possible method in ascertaining the position of drugs in culture and it has to be taken out at every hospital regularly. The research is developed to examine the prescription pattern of anticancer drugs in the clinical oncology unit of a tertiary care centre in India. The patient's demographic data, medication name, type, dose, intensity and duration etc., have been analyzed in each prescription  Commonly utilized anticancer narcotics and different forms of cancer were identified and the national essential drug list percentage of the medicines used was analysed. The current study intended to assess the tendencies and pattern of prescribing anticancer drugs. The prescribing practises were apposite and were in agreement with WHO strategies. The present study seemed to sustenance best proposing performs in order to endorse cost effective treatment and improved health care delivery.

Full text article

Generated from XML file

References

Ali, Imran, W. A., Wani, K., Saleem 2011. Cancer scenario in India with future perspectives. Cancer therapy, 8:56–70.

Bajracharya, N., Karki, P., Sapkota, S., Bastakoti, S., Yagol, N., Khan, G. M., Shakya, R., Rao, B. S. 2006. Prevalence pattern of cancer and handling of cytotoxic drugs. Kathmandu University Journal of Science, Engineering and Technology, 2(1):1–7.

Barbour, S. Y. 2012. Corticosteroids in the Treatment of Chemotherapy-Induced Nausea and Vomiting. Journal of the National Comprehensive Cancer Network, 10(4):493–499. ISSN 1540-1405, 1540-1413.

Grond, S., Zech, D., Diefenbach, C., Bischoff, A. 1994. Prevalence and pattern of symptoms in patients with cancer pain: A prospective evaluation of 1635 cancer patients referred to a pain clinic. Journal of Pain and Symptom Management, 9:372–382. ISSN 0885-3924.

Lajer, H., Daugaard, G. 1999. Cisplatin and hypomagnesemia. Cancer Treatment Reviews, 25(1):47–58. ISSN 0305-7372.

Manichavasagam, M., P, Martin, J. M., Lavanya, R., Karthik, S., Seenivasan, P. 2017. Prescribing pattern of anticancer drugs in a medical oncology department of a tertiary care teaching hospital. Annals of Medical and Health Sciences Research, (7).

Murthy, N., Srinivasa, D., Rajaram, M. S., Gautham, N. S., Shivaraj, B. S., Nandakumar, S., Pruthvish 2011. Risk of cancer development in India. Asian Pac J Cancer Prev, 12(2):20–20.

Pentareddy, M. R., Suresh, A. V. S., Shailendra, D., Subbaratnam, Y., Prasuna, G., Naresh, D. T. V., Rajshekar, K. 2015. Prescription pattern of anticancer drugs in a tertiary care hospital. Journal of Evidence Based Medicine and Healthcare, 2(20):3001–3009. ISSN 2349-2562, 2349-2570.

Posner, M. R., Glisson, B., Frenette, G., Al-Sarraf, M., Colevas, A. D., Norris, C. M., Seroskie, J. D., Shin, D. M., Olivares, R., Garay, C. A. 2001. Multicenter Phase I-II Trial of Docetaxel, Cisplatin, and Fluorouracil Induction Chemotherapy for Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck. Journal of Clinical Oncology, 19(4):1096–1104. ISSN 0732-183X, 1527-7755.

Rajanandh, M. G., Scott, J. X., Reddy, J. S., Raju, J. M., Kaniarivi, M., Raj, K. R. 2018. Pattern of complementary and alternative medicine use in pediatric oncology patients in a South Indian hospital. Journal of Cancer Research and Practice, 5(1):20–23. ISSN 2311-3006.

Shetty, V., Mathew, M., Mateti, U., Saj, N., Philip, M. 2019. Drug utilization evaluation of anticancer drugs in a charitable hospital. Indian Journal of Medical and Paediatric Oncology, 40(1), page :105. ISSN 0971-5851.

Surendiran, A., Balamurugan, N., Gunaseelan, K., Akhtar, S., Reddy, K. S., Adithan, C. 2010. Adverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative study. Indian Journal of Pharmacology, 42(1), page:40. ISSN 0253-7613.

Takiar, R., Nadayil, D., Nandakumar, A. 2010. Projections of number of cancer cases in India (2010- 2020) by cancer groups. Asian Pacific Journal of Cancer Prevention: APJCP, 11(4):1045–1049.

Williams, R. R., Hunt, S. C., Heiss, G., Province, M. A., Bensen, J. T., Higgins, M., Chamberlain, R. M., Ware, J., Hopkins, P. N. 2001. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (The Health Family Tree Study and the NHLBI Family Heart Study). The American Journal of Cardiology, 87(2):129–135. ISSN 0002-9149.

Authors

Pandiamunian Jayabal
jpandiamunian@gmail.com (Primary Contact)
Nithiya Dhanasekaran
Shanmugasundaram S
Pandiamunian Jayabal, Nithiya Dhanasekaran, & Shanmugasundaram S. (2021). Recommending form of anticancer drugs in oncology unit of a tertiary care teaching hospital. International Journal of Research in Pharmaceutical Sciences, 12(2), 1201–1207. Retrieved from https://ijrps.com/home/article/view/144

Article Details

No Related Submission Found